ATRA
Atara Biotherapeutics
$7.71
−$0.19 (−2.41%)Jul 27, 2026
Key metrics
The numbers that frame ATRA today
- Market cap
- $69.47M
- P/E (TTM)
- -7.3
- EV / FCF
- -4.5
- Gross margin
- 96.1%
- EV / Sales
- 4.8
- ROIC
- -10.2%
- Div yield
- 0%
- 52wk Low
- $3.92
- 52wk High
- $19.15
Growth
Revenue and earnings trend for ATRA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ATRA
Is Atara Biotherapeutics a good buy?
Yes. Atara Biotherapeutics has strong quality and excellent momentum. Both signals support the setup. Growth looks poor, a caveat that does not overturn the setup. We think Atara Biotherapeutics is selling at a very high price, which cuts against the buy case.
What is the market capitalization of ATRA?
Atara Biotherapeutics's market capitalization is $69.47M.
What is the P/E ratio for ATRA stock?
Atara Biotherapeutics's current P/E ratio is -7.3.
What is the 52-week high for ATRA stock?
The 52-week high for Atara Biotherapeutics is $19.15. The current close of $7.71 is 59.7% below that high.
What is the 52-week low for ATRA stock?
The 52-week low for Atara Biotherapeutics is $3.92. The current close of $7.71 is 96.7% above that low.
Does ATRA stock pay dividends?
Atara Biotherapeutics does not currently show a dividend per share in the company data.